Dermatologist Malpractice Insurance Cost 2026: What Mohs, Cosmetics, and Missed Melanoma Really Do to Your Premium

What does dermatologist malpractice insurance actually cost, and why is the spread so wide?

Here is my read, up front. A medical dermatologist who does little surgery or cosmetics in a low-rate state often pays somewhere around $5,000 to $12,000 a year. A dermatologist running heavy Mohs surgery plus cosmetic and laser work, or practicing in a high-cost state, can land at $20,000 to $50,000 or more. Four- or five-fold swings inside a single specialty are normal. None of these figures is a quote from any carrier; they describe the rough shape of the market, and your actual rate turns on how a single application is filled out.

Dermatology gets lumped in with the “cheap specialties,” and that is not wrong for medical derm: rates sit well below OB/GYN, neurosurgery, and general surgery. The trap is treating that as fixed. Modern dermatology is not a rash-and-acne clinic anymore. It removes skin cancer with Mohs, injects neurotoxins and fillers, runs lasers, and sometimes performs liposuction. The more a practice tilts toward the scalpel and the laser, the closer its rate moves to a surgical specialty.

My approach is to treat the malpractice policy as a mirror of the practice rather than a line item. A carrier is pricing exactly two things: the probability you get a claim next year, and the average payout if one lands. In dermatology, the two numbers that push both of those up the most are missed melanoma and cosmetic complications. The moment you request a quote is also the moment you see your own risk profile written as a number.

It helps to know what claims actually pay before you argue about limits and policy wording. I lay out how payouts are structured in the medical malpractice settlement amount guide, and reading it alongside this makes the limit decisions below far more concrete.

---

Which variables move a dermatology premium the most?

Rate sheets look busy, but six variables do most of the work: state, procedure mix, how you handle biopsy and pathology, claims history, limits and policy form, and board certification.

Variable	Effect on premium	What it means in practice
State and county	Very large	South Florida, New York, and Cook County (IL) run high; states with non-economic damage caps run lower
Procedure mix	Very large	Medical-only is the baseline; Mohs, cosmetic, and laser raise the rate
Biopsy and pathology tracking	Large	Missed biopsies, untracked results, and melanoma false negatives are the core path to big claims
Claims and discipline history	Large	A paid claim in the last 5 years surcharges you; repeats can mean a declination
Limits and policy form	Moderate	1M/3M is standard; occurrence costs more in year one than claims-made
Board certification	Moderate	ABD certification earns credit; non-certified means higher rates or limited appetite

State does the heaviest lifting. US malpractice pricing follows each state’s litigation climate. The gap between states with non-economic damage caps and states without them is large, and some states run a separate patient compensation fund that changes the structure of the personal policy itself. If you are deciding where to open, the premium alone can differ by tens of thousands of dollars a year.

Procedure mix is next, and it is the heart of dermatology underwriting. The application asks how many Mohs cases you do, which cosmetic procedures you perform, which lasers you run, and whether you do liposuction. How you answer those lines is your rate class.

---

Why is missed melanoma the biggest exposure in dermatology?

Every dermatologist knows this clinically, but it deserves to be restated from the insurance seat. Skin cancer, and melanoma in particular, sits at the center of dermatology litigation. A 2025 review of skin cancer cases litigated between 1930 and 2025 found melanoma accounted for roughly half of them, and the most common allegation was failure or delay in diagnosis. In that same analysis, family physicians were the most frequent defendants, with dermatologists, including Mohs surgeons, right behind them.

Why melanoma? Because the outcome is catastrophic and the chain of responsibility is legible. A patient gets a skin check, is diagnosed with metastatic melanoma two years later, and every note in between becomes evidence. The patterns repeat:

• Not biopsying. An ambiguous lesion gets “watchful waiting” instead of a tissue sample.
• Untracked pathology. The biopsy was done, but there is no system to deliver a malignant result to the patient or to chase it, so it is buried.
• Follow-up failure. A high-risk patient (prior melanoma, multiple atypical nevi) slips past the recall interval.
• Pathology read error. The dermatologist reads the specimen and calls a melanoma benign, a false negative.

That last one deserves extra caution. In studies of pathology-related claims, false-negative melanoma was a leading cause. If you read your own slides, a simple rule that routes ambiguous specimens to a dermatopathologist cuts a large slice of that exposure.

Carriers know this structure cold, which is why dermatology applications ask how you track pathology results and whether you have a protocol for notifying patients of malignant findings. A disciplined tracking system is both a rate credit and the single strongest defense exhibit if a suit ever lands.

---

How much do Mohs and cosmetic-laser work raise the rate?

Carriers grade procedure mix by surgical content. The grid below is the common industry intuition, not any one carrier’s rate table.

Practice profile	Relative risk	Rough premium direction (same state)
Medical-focused (rashes, acne, psoriasis, routine biopsy)	Low	Baseline
Mohs surgery, limited reconstruction	Moderate	About 1.3x to 1.8x baseline
Heavy cosmetic and laser (tox, fillers, laser, IPL)	Moderate-high	About 1.5x to 2.5x baseline
Liposuction, general-anesthesia cosmetic surgery	High	Separate underwriting, surcharge or exclusion possible
Medspa with substantial staff-performed procedures	High	Separate entity and staff coverage, structure redesign

Mohs raises rates less than pure cosmetic surgery because it is cancer treatment. But it is still a scalpel procedure, so it brings margin disputes (incomplete excision and recurrence), wrong-site risk, and dissatisfaction with scarring and reconstruction. The wider the reconstruction and the more general anesthesia is involved, the closer the rate moves to a surgical class.

Cosmetic and laser work is different in kind. Laser burns, pigment changes, filler or injectable vascular occlusion (at worst, skin necrosis or blindness), and liposuction complications are all injuries on procedures the patient did not medically need, so juries award generously. Because the patient arrives expecting improvement rather than treatment for a disease, a result that misses expectations turns into a claim even without a true complication.

The most-missed gap here is the medspa and staff-performed procedures. Many dermatologists assume “my policy covers it all,” but most personal malpractice policies cover only the physician’s own professional acts. Laser and filler treatments performed by a nurse or esthetician, and your liability as medical director, are separate items: when a staff member causes a laser burn, whether your personal policy covers that supervisory liability depends entirely on the wording. Layering those staff and premises exposures is the same logic I walk through in the commercial umbrella insurance cost guide. And if your practice employs staff, the employer liability in the workers’ comp premium guide is a separate line you carry alongside malpractice.

---

How should I handle claims-made, occurrence, and tail?

This is the question dermatologists ask most. My default is to start claims-made and price the tail in advance when a move or a sale looks likely. The reasons are in the table.

Item	Claims-made	Occurrence
Trigger	Policy active when the claim is filed	Policy active when the incident happened
First-year premium	Low	High, often several times claims-made
Premium path	Steps up by policy year (mature rate)	Generally flat from the start
Leaving or closing	Needs tail	No tail needed
Switching carriers	Must manage the retroactive date	Simple
Best fit	Early practice, cost minimization	Long-term single practice, likely to move

The blind spot in claims-made is the “mature rate.” Year one is cheap, then it climbs annually until it levels off around year five. If you pick the cheapest first-year quote and stop there, the annual step-ups will surprise you, so ask for a five-year projected rate schedule.

Tail (an extended reporting endorsement) covers claims reported after a claims-made policy ends. It matters more in dermatology than in most fields because skin cancer suits are commonly filed years after the visit. That is why you keep biopsy records and clinical photos for a long time, and why tail is effectively mandatory: a claim can land after you have closed. Cost is usually a one-time charge of 150% to 250% of the last annual premium. A few practical notes:

• If your next carrier grants prior-acts coverage back to your original retroactive date, you may not need to buy separate tail.
• Some policies provide free tail at retirement, death, or permanent disability after a minimum enrollment period. Comparing that clause early can save you tens of thousands later.
• The window to buy tail after a policy ends is short, usually 30 to 60 days. Miss it and it may no longer be available.

---

What actually lowers the premium?

Cutting limits is the worst lever. If you fall below the 1M/3M that hospital privileges and insurer panels require, you lose the ability to practice in those settings, and the savings from a lower limit are smaller than people expect. The high-impact moves reduce risk.

1. Keep board certification. Maintaining American Board of Dermatology (ABD) certification is the baseline for rate credit and underwriting acceptance.
2. Build a biopsy and pathology tracking system. A malignant-result notification protocol and a recall system are the most effective device against melanoma claims, and carriers score it.
3. Set a pathology referral rule. Routing ambiguous specimens to a dermatopathologist cuts false-negative exposure.
4. Adjust the procedure mix. Trimming or staging the highest-risk work (liposuction, general-anesthesia cosmetics) can move the rate class itself.
5. Standardize consent and photos. Pre- and post-procedure photos, risk disclosure, and documented expectations are core defense exhibits for cosmetic work.
6. Complete risk-management CME. Many carriers give a single-digit percentage discount for an annual risk course.
7. Compare several brokers. The same application draws different appetite from different carriers; heavy cosmetic or surgical practices declined in the standard market are often placed in the excess and surplus (E&S) market.

Of these, adjusting procedure mix and building the tracking system move the needle most. Changing your rate class beats chasing a few points of discount.

---

What mistakes do dermatologists make most?

Most of the damage comes not from the premium number but from the application and the structure.

• Material misrepresentation. Understating cosmetic/laser volume or liposuction. The single most common cause of a rescinded policy.
• The medspa gap. Assuming staff-performed procedures and supervisory liability are inside a personal policy.
• Retroactive date break. Switching carriers without carrying the retroactive date forward, leaving past care unprotected.
• Ignoring tail. Learning there is no coverage only after a skin cancer claim arrives post-move or post-closure.
• Not checking defense-cost structure. Whether defense costs erode the limit, whether there is a license-defense sublimit, and where the consent-to-settle clause sits never appear in the premium figure.

Disputes also arise in how an insurer settles or handles a claim. The way carrier claim handling and coverage denials turn into legal fights follows the same principles I cover in the insurance claim and bad-faith dispute guide. Because a public settlement directly affects reputation in cosmetic practice, confirm whether the insurer can settle without your consent.

The clauses that matter as much as price: are defense costs outside the limit, is the license-defense sublimit adequate, does the consent-to-settle clause favor you, and in a high-verdict venue do you need an excess layer. I would not pick a policy with defense costs inside the limit just because the premium is five percent cheaper.

---

How should I prepare for a quote?

If this is your first time shopping, this order is efficient.

Step	Task	Timing
1	Document the last 5 years of procedure mix (medical, Mohs, cosmetic, laser)	4 to 6 weeks before quoting
2	Write down the biopsy/pathology tracking and malignant-notification protocol	4 weeks before
3	Request and review loss runs	3 to 4 weeks before
4	Diagram medspa/staff-procedure structure and facility accreditation	3 weeks before
5	Send the same packet to 2 or 3 specialist brokers	2 weeks before
6	Compare limits, defense costs, consent, and tail clauses in writing	30 days before renewal

Following this order keeps you from rushing into an expensive policy days before renewal; start the renewal 60 to 90 days before expiration. If your practice also self-funds employee health benefits, that risk-transfer mechanic is its own topic in the stop-loss insurance guide. And for how premiums and practice finances are handled on the tax side, the expense-treatment lens in the capital gains tax guide fits here.

---

Related reading

• 👉 Medical Malpractice Settlement Amount Guide 2026
• 👉 Commercial Umbrella Insurance Cost Guide 2026
• 👉 Workers’ Comp Insurance Premium Guide 2026
• 👉 Self-Funded Health Plan Stop-Loss Insurance Guide 2026

---

This article is for general informational purposes only and is not insurance, legal, or tax advice. The premium ranges here describe rough market tendencies, not an actual quote from any carrier, and vary widely by state, insurer, procedure mix, and individual history. Before you buy, consult a licensed insurance broker, an attorney, and an accountant, and read the policy’s coverage and exclusions yourself.